Type 1 diabetes (T1D) is an autoimmune condition in which the body's own immune system attacks insulin-producing cells. As a ...

Long-Term Effects of Ozempic This article was reviewed by Lynn Marie Morski, MD, JD. You may have heard about — or maybe even ...

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

Sustained GLP-1 receptor agonist therapy is linked to greater improvements in A1c levels than DPP-4 inhibitor therapy in patients with type 2 diabetes, a Danish real-world analysis shows.

Combining GLP-1 medications with 8 healthy lifestyle habits reduced the risk of major adverse cardiovascular events, or MACE, ...